Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
about
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid CancerUltrasensitive Antibody Detection by Agglutination-PCR (ADAP)2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerMeasurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies.Diagnostic Performance of 18F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative 131I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb Level.Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodiesThe effect of chronic lymphocytic thyroiditis on patients with thyroid cancer.Association of Hashimoto's thyroiditis with thyroid cancer.Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma.Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.Thyroglobulin antibody resolution after total thyroidectomy for cancer.Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.Estimation of true serum thyroglobulin concentration using simultaneous measurement of serum antithyroglobulin antibody.Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?Incidental thyroid carcinoma diagnosed after total thyroidectomy for benign thyroid diseases: incidence and association with thyroid disease type and laboratory markers.Serum thyroglobulin antibody levels within or near to the reference range may interfere with thyroglobulin measurementThyroid functional parameters and correlative autoantibodies as prognostic factors for differentiated thyroid cancers.Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms.Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.Thyroglobulin Antibody Screen Prior to Mass Spectrometry Provides Measurable Cost Savings and Optimal Laboratory Utilization.Clinicopathological relevance of antithyroglobulin antibodies in low-risk papillary thyroid cancer.Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma.Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.Thyroglobulin as early prognostic marker to predict remission at 18-24 months in differentiated thyroid carcinoma.Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.Unfavorable efficacy to 131I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb.Preoperative Serum Thyrotropin to Thyroglobulin Ratio Is Effective for Thyroid Nodule Evaluation in Euthyroid Patients.The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level.Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications.Is there a role for an ultrasensitive thyroglobulin assay in patients with serum antithyroglobulin antibodies? A large (Australian) cohort study in differentiated thyroid cancer.Evaluation of the highly sensitive Roche thyroglobulin II assay and establishment of a reference limit for thyroglobulin-negative patient samples.In-House Solid-Phase Radioassay for the Detection of Anti-thyroglobulin Autoantibodies in Patients with Differentiated Thyroid Cancer.The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review.
P2860
Q26829349-FD3C672B-B777-40BC-ABE2-7A356A0D4BEDQ28391166-6F6BF8C1-FD9C-4004-96D5-3C6AD85C0180Q30367068-ED2EBAD5-6D6B-4487-B07B-1897FBE8E4C8Q33594636-AFAC0F5D-6D97-4417-ABA8-9FFA1BE8CB91Q33767437-A4EAC991-BD05-43FC-9999-E7526A726265Q33842355-D9B429B0-97E7-417B-B485-1B51BEC1FA74Q34103836-BE2551F4-B70B-4226-9544-360282EF3561Q34134307-B6781707-EAAF-4872-9DEF-AD6E01F5F14FQ34174513-91A9D259-353F-49EA-9E65-47323D214AF6Q34296102-AF10E6A4-330A-40DB-9519-545BEED25C85Q35913462-812C8C95-FBAD-4A6F-9BFE-BE004AAA8252Q35916507-387F953E-A586-49F5-8CDB-209FF6729799Q36030813-E31EE5D6-12E6-4E2A-97CF-7AAD2BDB56FFQ36736452-BB256A15-AD34-4D85-B52A-86637C519DFBQ36765555-5C9855AB-3479-4D5C-B10E-CA2E219E8CCCQ36903964-F68CDF1C-F825-4559-BF52-11D54BA91F03Q37368194-16D369EE-D404-49AA-AF52-7DBDF139F280Q37508392-51CCF41C-3D9B-466A-87A8-141A850E6788Q37580338-56602B53-2E5F-45D3-BC66-F35F2B312F96Q38137369-15A85935-D4F9-4EB0-95B6-5F54FB8153EDQ38716870-E3FBD33C-98CB-44B9-836A-08A2F870A778Q38844250-207AA000-89C7-4710-A3E4-356C16E68C60Q39106373-4FA35C5D-B2BD-48A6-824E-31C8897596F6Q40415359-02E9D5EF-0FD7-41D5-8A1D-85C4CAC6E45EQ40433547-E6FA9A5B-185F-44E4-8DE4-BD861FC5D466Q41772758-D7C9CC8D-807F-4698-AD03-D48A6BDAB27CQ42247393-FA374147-22EC-4485-AD9B-21217763D7C9Q42967381-D6042309-97B0-421C-9E9D-48F340FA23F5Q43746499-1019EA45-65F2-4A47-9BD5-B3CD3C72D4C2Q45780286-3D4106B6-0875-43BE-91DB-CA3014D8E742Q47120994-03BABD76-880D-40E6-BE98-F54DDE80B6DBQ49704998-AEEE1407-0393-413C-B89E-67CAB9390D74Q50564321-213CF865-8BCE-43F0-A9A3-27EAD59BDA7DQ51120965-B03B34BD-1499-4C5C-AD4B-BBECC1B3B599Q51322666-0ACD7BFE-7233-41ED-BC1D-AB3B3E20E867Q51327287-AA33AFB4-027D-4DC2-BF4B-AA38436484E8Q53618236-68C5B203-C7D1-4344-B236-D3C1E58D44CBQ55069933-AAC6F2AD-5534-4FD5-ACA4-C6A9A28B4C62Q55077983-994AEE1F-5A75-44E7-86AC-4710D0E7A66EQ55101444-9140DAA7-B6E6-46B0-A851-38120A0DD96F
P2860
Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical review: Clinical util ...... ntiated thyroid cancers (DTC).
@en
Clinical review: Clinical utility of thyroglobulin antibody
@nl
type
label
Clinical review: Clinical util ...... ntiated thyroid cancers (DTC).
@en
Clinical review: Clinical utility of thyroglobulin antibody
@nl
prefLabel
Clinical review: Clinical util ...... ntiated thyroid cancers (DTC).
@en
Clinical review: Clinical utility of thyroglobulin antibody
@nl
P356
P1476
Clinical review: Clinical util ...... ntiated thyroid cancers (DTC).
@en
P2093
Carole A Spencer
P304
P356
10.1210/JC.2011-1740
P407
P577
2011-09-14T00:00:00Z